GET

Trial List

List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/?page=77
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 802,
    "next": "http://api.gregory-ms.com/trials/?page=78",
    "previous": "http://api.gregory-ms.com/trials/?page=76",
    "results": [
        {
            "trial_id": 38,
            "title": "Therapeutic Adherence of Multiple Sclerosis Patients",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: Study of the role of sociocognitive factors<br/><b>Sponsor</b>:    Lille Catholic University<br/><b>Not yet recruiting</b>",
            "published_date": "2021-04-08T16:00:00Z",
            "discovery_date": "2021-04-08T11:57:29Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04837352?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 42,
            "title": "Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Demyelinating Autoimmune Diseases, CNS;   Autoimmune Diseases of the Nervous System;   Nervous System Diseases;   Demyelinating Diseases;   Autoimmune Diseases;   Immune System Diseases;   Pathologic Processes<br/><b>Intervention</b>:    Device: Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test<br/><b>Sponsor</b>:    Dragonfly Research, LLC<br/><b>Recruiting</b>",
            "published_date": "2021-04-08T16:00:00Z",
            "discovery_date": "2021-04-08T11:57:29Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04837651?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 41,
            "title": "Retrospective Study on Registry Data to Evaluate the Impact of Ocrelizumab Used in Routine Care in Patients With RRMS",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    <br/><b>Sponsor</b>:    University Hospital, Strasbourg, France<br/><b>Recruiting</b>",
            "published_date": "2021-04-08T16:00:00Z",
            "discovery_date": "2021-04-08T11:57:29Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04838015?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 40,
            "title": "Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Covid19<br/><b>Intervention</b>:    <br/><b>Sponsor</b>:    St. Barnabas Medical Center<br/><b>Recruiting</b>",
            "published_date": "2021-04-07T16:00:00Z",
            "discovery_date": "2021-04-08T11:57:29Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04834401?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 39,
            "title": "Impact of Neuropsychological Disorders in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: Three dimensional gait analysis with eyetracking<br/><b>Sponsor</b>:    Lille Catholic University<br/><b>Not yet recruiting</b>",
            "published_date": "2021-04-08T16:00:00Z",
            "discovery_date": "2021-04-08T11:57:29Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04837365?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 37,
            "title": "The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis, Relapsing-Remitting;   Pain, Chronic;   Fatigue Syndrome, Chronic;   Kinesiophobia<br/><b>Interventions</b>:    Behavioral: PMR: Progressive Muscle Relaxation;   Behavioral: BRT:Benson Relaxation Technique<br/><b>Sponsor</b>:    Hacettepe University<br/><b>Completed</b>",
            "published_date": "2021-04-06T16:00:00Z",
            "discovery_date": "2021-04-06T11:14:24Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04833673?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 35,
            "title": "Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: Exposure to methylprednisolone during pregnancy<br/><b>Sponsors</b>:    Jena University Hospital;   Ruhr University of Bochum;   Interdisciplinary Center of Clinical Research of the Medical Faculty Jena;   Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany<br/><b>Recruiting</b>",
            "published_date": "2021-04-05T16:00:00Z",
            "discovery_date": "2021-04-05T11:38:24Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04832269?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 36,
            "title": "Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants",
            "summary": "<b>Condition</b>:    Relapsing Remitting Multiple Sclerosis<br/><b>Intervention</b>:    Drug: Natalizumab<br/><b>Sponsor</b>:    Biogen<br/><b>Recruiting</b>",
            "published_date": "2021-04-05T16:00:00Z",
            "discovery_date": "2021-04-05T11:38:24Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04832399?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 34,
            "title": "Imaging Evaluation of Central Nervous Autoimmune Diseases",
            "summary": "<b>Conditions</b>:    MS (Multiple Sclerosis);   NMO Spectrum Disorder<br/><b>Intervention</b>:    Diagnostic Test: MRI<br/><b>Sponsor</b>:    Qilu Hospital of Shandong University<br/><b>Not yet recruiting</b>",
            "published_date": "2021-03-30T16:00:00Z",
            "discovery_date": "2021-03-30T11:05:24Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04822623?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 33,
            "title": "Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Biological: Mesenchymal Stem Cells (MSC)<br/><b>Sponsor</b>:    Hadassah Medical Organization<br/><b>Completed</b>",
            "published_date": "2021-03-30T16:00:00Z",
            "discovery_date": "2021-03-30T11:05:24Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04823000?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        }
    ]
}